BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22384039)

  • 1. High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana.
    Shapiro RL; Souda S; Parekh N; Binda K; Kayembe M; Lockman S; Svab P; Babitseng O; Powis K; Jimbo W; Creek T; Makhema J; Essex M; Roberts DJ
    PLoS One; 2012; 7(2):e31580. PubMed ID: 22384039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.
    Chen JY; Ribaudo HJ; Souda S; Parekh N; Ogwu A; Lockman S; Powis K; Dryden-Peterson S; Creek T; Jimbo W; Madidimalo T; Makhema J; Essex M; Shapiro RL
    J Infect Dis; 2012 Dec; 206(11):1695-705. PubMed ID: 23066160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana.
    Powis KM; McElrath TF; Hughes MD; Ogwu A; Souda S; Datwyler SA; von Widenfelt E; Moyo S; Nádas M; Makhema J; Machakaire E; Lockman S; Essex M; Shapiro RL
    J Acquir Immune Defic Syndr; 2013 Apr; 62(5):517-24. PubMed ID: 23344545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
    Sebitloane HM; Moodley J
    Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.
    Joseph O; Biodun O; Michael E
    J Coll Physicians Surg Pak; 2011 Jun; 21(6):356-9. PubMed ID: 21711992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4(+) cell counts in Gaborone, Botswana.
    Chen JY; Ogwu AC; Svab P; Lockman S; Moffat HJ; Gaolathe T; Moilwa S; Størdal K; Dryden-Peterson S; Moffat C; Makhema J; Essex M; Shapiro RL
    J Acquir Immune Defic Syndr; 2010 May; 54(1):102-6. PubMed ID: 19864957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants.
    Frederick T; Homans J; Spencer L; Kramer F; Stek A; Operskalski E; Kovacs A
    Clin Infect Dis; 2012 Sep; 55(6):877-84. PubMed ID: 22675157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.
    Conroy AL; McDonald CR; Gamble JL; Olwoch P; Natureeba P; Cohan D; Kamya MR; Havlir DV; Dorsey G; Kain KC
    Am J Obstet Gynecol; 2017 Dec; 217(6):684.e1-684.e17. PubMed ID: 29031892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV, Placental Lesions, and Adverse Perinatal Outcomes.
    Maswime S; Pule C; Mtshali Z; Chawana R; Matjila M
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S691-S693. PubMed ID: 34882204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.
    Bae WH; Wester C; Smeaton LM; Shapiro RL; Lockman S; Onyait K; Thior I; Essex M
    AIDS; 2008 Aug; 22(13):1633-40. PubMed ID: 18670224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.
    Dryden-Peterson S; Shapiro RL; Hughes MD; Powis K; Ogwu A; Moffat C; Moyo S; Makhema J; Essex M; Lockman S
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):428-36. PubMed ID: 21266910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal HIV infection and risk of adverse pregnancy outcomes in Hunan province, China: A prospective cohort study.
    Li H; Liu J; Tan D; Huang G; Zheng J; Xiao J; Wang H; Huang Q; Feng N; Zhang G
    Medicine (Baltimore); 2020 Feb; 99(8):e19213. PubMed ID: 32080112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana.
    Parekh N; Ribaudo H; Souda S; Chen J; Mmalane M; Powis K; Essex M; Makhema J; Shapiro RL
    Int J Gynaecol Obstet; 2011 Oct; 115(1):20-5. PubMed ID: 21767835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.
    French CE; Tookey PA; Cortina-Borja M; de Ruiter A; Townsend CL; Thorne C
    Antivir Ther; 2013; 18(2):183-92. PubMed ID: 23475123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana.
    Powis KM; Smeaton L; Ogwu A; Lockman S; Dryden-Peterson S; van Widenfelt E; Leidner J; Makhema J; Essex M; Shapiro RL
    J Acquir Immune Defic Syndr; 2011 Feb; 56(2):131-8. PubMed ID: 21124227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana.
    Dryden-Peterson S; Jayeoba O; Hughes MD; Jibril H; Keapoletswe K; Tlale J; Modise TA; Asmelash A; Moyo S; van Widenfelt E; Makhema J; Essex M; Shapiro RL; Lockman S
    J Acquir Immune Defic Syndr; 2011 Nov; 58(3):353-7. PubMed ID: 21792062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral treatment during pregnancy.
    Keiser O; Gayet-Ageron A; Rudin C; Brinkhof MW; Gremlich E; Wunder D; Drack G; Hirschel B; de Tejada BM; ;
    AIDS; 2008 Nov; 22(17):2323-30. PubMed ID: 18981771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
    Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B
    AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.